Alkermes Pharma Ireland filed suit against Par Pharmaceuticals over two patents related to multiparticulate modified release compositions. 11/11, District of Delaware, 1:2011cv01119.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
